期刊文献+

循环microRNAs与局灶节段性肾小球硬化患者疾病活动的关系 被引量:4

Circulating microRNAs and the disease activity of patients with focal segmental glomerulosclerosis
下载PDF
导出
摘要 目的:分析循环中与局灶节段性肾小球硬化(FSGS)患者疾病活动相关microRNAs(miRNAs),为后续探讨循环miRNAs在FSGS发病中的作用奠定基础。方法:选取年龄、性别匹配的活动性FSGS患者及正常对照各9例,提取FSGS患者及对照组血浆总RNA,采用TaqMan低密度芯片(TaqMan Low Density Array)进行miRNA表达谱分析,筛选出在活动性FSGS患者循环中表达上调的miRNAs分子;然后再选取32例活动性FSGS患者血浆,采用实时荧光定量逆转录聚合酶链反应(qRT-PCR)方法对筛选出的miRNAs分子进行验证,同时与非活动性FSGS患者进行比较。采用ROC曲线分析循环miRNA区分活动性FSGS、非活动性FSGS和正常对照的效能。结果:与正常对照相比,活动性FSGS患者循环miRNA-125b,miRNA-186和miRNA-193a-3p水平显著上调(P<0.05)。ROC曲线分析显示,循环miRNA-125b、miRNA-186和miRNA-193a-3p区分活动性FSGS与正常对照的ROC曲线下面积(AUC)分别为0.882、0.789和0.910。与非活动性FSGS相比,活动性FSGS患者循环中miRNA-186水平也明显上调。结论:活动性FSGS患者循环miRNA-125b、miRNA-186及miRNA-193a-3p较正常对照显著升高,其中miRNA-186的升高与疾病的活动性关系更密切。 Objective:To analyze the elationship between circulating miRNAs and the disease activity of patients with FSGS,and explore the role of circulating miRNAs in the pathogenesis of FSGS.Methodology:miRNAs expression profile was performed on 2 pooled plasma samples from nine patients with active FSGS and 9 normal controls using TaqMan Low Density Array.A panel of differential expressed miRNAs were found,and then validated by quantitative reverse transcription PCR (qRT-PCR) array with individual plasma samples.Meanwhile,plasma samples from non-active FSGS patients were examined for candidate miRNAs.Receiver-operatin characteristic (ROC) curves were established to analyze the value of circulating miRNAs for differentiating active FSGS from non-active FSGS and healthy controls.Results:The results of TaqMan Low Density Array indicated that a panel of miRNAs was deregulated in plasma of active FSGS patients.After large scale independent cohort validation by qRT-PCR,the levels of circulating miRNA-125b,miRNA-186 and miRNA-193a-3p were significantly increased in active FSGS patients compared with that in normal controls.ROC curve analysis showed that circulating miRNA-125b,miRNA-186 and miRNA-193a-3p was a significant value for differentiating active FSGS from normal controls.In addition,the level of circulating miRNA-186 was also significantly increased in active FSGS patients when compared with non-active FSGS patients.Conclusion:We determined that the levels of circulating miRNA-125b,miRNA-186 and miRNA-193a-3p were increased in patients with active FSGS and miR-186 showed a more closer relationship with FSGS activity.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2013年第4期309-314,323,共7页 Chinese Journal of Nephrology,Dialysis & Transplantation
基金 国家重点基础研究发展计划(973计划)No.2012CB517600(2012CB517606)
关键词 局灶节段性肾小球硬化 MICRORNA 疾病活动 focal segmental glomerulosclerosis circulating microRNA disease activity
  • 相关文献

参考文献30

  • 1Hoyer JR,Vernier RL,Najarian JS,et al.Recurrence of idiopathic nephrotic syndrome after renal transplantation.Lancet,1972,2(7773):343-348.
  • 2Mu(n)oz J,Sanchez M,Perez-Garcia R,et al.Recurrent focal glomerulosclerosis in renal transplants proteinuria relapsing following plasma exchange.Clin Nephrol,1985,24(4):213-214.
  • 3Artero ML,Sharma R,Savin V J,et al.Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis.Am J Kidney Dis,1994,23 (4):574-581.
  • 4Savin V J,Sharma R,Sharma M,et al.Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.N Engl J Med,1996,334 (14):878-883.
  • 5Sharma M,Sharma R,Reddy SR,et al.Proteinuria after injection of human focal segmental glomerulosclerosis factor.Transplantation,2002,73 (3):366-372.
  • 6Sharma M,Sharma R,McCarthy ET,et al." The FSGS factor:"enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma.J Am Soc Nephrol,1999,10 (3):552-561.
  • 7陈朝红,刘志红,秦卫松,张炯,洪亦眉,张文,黎磊石.利用体外培养足细胞针对局灶节段性肾小球硬化患者的循环因子进行检测[J].肾脏病与透析肾移植杂志,2009,18(1):3-12. 被引量:11
  • 8Zhang Y,Liu D,Chen X,et al.Secreted Monocytic miRNA-150Enhances Targeted Endothelial Cell Migration.Mol Cell,2010,39(1):133-144.
  • 9Chen X,Liang H,Zhang J,et al.Secreted microRNAs:a new form of intercellular communication.Trends Cell Biol,2012,22 (3):125-132.
  • 10Mittelbrunn M,Gutiérrez-Vázquez C,Villarroya-Beltri C,et al.Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells.Nat Commun,2011,2:282.

二级参考文献31

  • 1Savin VJ, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin inrecurrent focal segmental glomerulosclerosis. N Engl J Med, 1996, 334 : 878 - 883.
  • 2Savin V J, Mccarthy ET, Sharma M. Pereability factors in focal segmental glomerulosclerosis. Semin Nephrol, 2003, 23 : 147 - 160.
  • 3Cattran D, Neogi TA, Sharma R, et al. Serial estimates of serum permeability activity and clinical correlates in patients with native kidney focal segmental glomerulosclerosis. J Am Soc Nephrol, 2003, 14 : 448 - 453.
  • 4Ichimura K, Kurihara H, Sakai T. Actin filament organization of foot processes in rate podocytes. J Histochem Cytoehem, 2003, 51:1589 - 1600.
  • 5Oh J, Reiser J, Mundel P. Dynamic(re) organization of the podocyte actin cytoskeleton in the nephritic syndrome. Pediatr Nephrol, 2004, 19 : 130 - 137.
  • 6Sharma M, Sharma R, McCarthy ET, et al. The focal segmental glomerulosclerosis permeability factor: biochemical characteristics and biological effects. Exp Biol Med (Maywood) , 2004, 229:85 -98.
  • 7Hoyer JR, Vernier RL, Najarian JS, et al. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet, 1972; 2:343 - 345.
  • 8Zimmerman SW. Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerularsclerosis after renal transplantation. Clin Nephrol, 1984, 22 : 32 - 35.
  • 9刘志红.微小病变性肾病及局灶阶段性肾小硬化//黎磊石,刘志红.中国肾脏病学.北京:人民军医出版社.2008:364-386.
  • 10Mundel P, Reiser J, zuniga Mejia Borja A, et al. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res, 1997, 236:248 -258.

共引文献10

同被引文献36

  • 1Saal S, Harvey SJ. MicroRNAs and the kidney : coming of age. Curr Opin Nephrol Hypertens, 2009,18 (4) : 317-323.
  • 2Kato M, Aree L, Natarajan R. MieroRNAs and their role in progressivekidney diseases.Clin J Am Soc Nephrol,2009,4(7) :1255-1266.
  • 3Marrone AK, Stolz DB, Bastacky SI, et al. MieroRNA-17 : 92 Is Required for Nephrogenesis and Renal Function. J Am Soc Nephrol, 2014,25(7) :1440-1452.
  • 4Ho J, Ng KH, Rosen S, et al. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J Am Soe Nephrol, 2008,19 ( 11 ) :2069-2075.
  • 5Harvey SJ, Jarad G, Cunningham J, et al. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease.J Am Soc Nephro1,2008,19( 11 ) :2150-2158.
  • 6Shi S, Yu L, Chiu C, et al.Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis.J Am Soc Nephro1,2008,19( 11 ) : 2159-2169.
  • 7Wu J, Zheng C, Fan Y, et al. Downregu|ation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids. J Am Soc Nephrol, 2014,25 ( 1 ) : 92-104.
  • 8Gebeshuber CA, Komauth C, Dong L, et al. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1.Nat Med ,2013,19 (4) :481-487.
  • 9Gao Y, Liu F, Fang L, et al. Genkwanin inhibits proinflammatory mediators mainly through the regulation of miR-101/MKP-1/MAPK pathway in LPS-activated macrophages. PLoS One, 2014, 9 (5) :e96741.
  • 10Zhu QY, Liu Q, Chen JX, et al. MicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages.J Immuno1,2010,185 (12) :7435-7442.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部